Zobrazeno 1 - 10
of 33
pro vyhledávání: '"K. Grasmäder"'
Autor:
Marie Luise Rao, Olrik von Widdern, Astrid Zobel, Marcella Rietschel, Ulrich Jaehde, A. Dragicevic, Wolfgang Maier, Christoph Hiemke, K Grasmäder, Kai-Uwe Kühn, Petra Louise Verwohlt
Publikováno v:
European Journal of Clinical Pharmacology. 60:473-480
Mirtazapine belongs to the new generation of antidepressants that is commonly used in clinical routine. Therefore, we feel it mandatory to control compliance in the context of non-response, adverse events or other clinical situations by means of plas
Publikováno v:
Journal of Chromatography B. 794:35-47
Therapeutic drug monitoring necessitates efficient, fast and reliable analytical methods validated by external quality control. We therefore devised an isocratic reversed-phase HPLC method with ultraviolet detection and optimised this to quantify mir
Autor:
W. Mletzko, M. L. Rao, A. Scherer, A. Dragicevic, B. Schanz, C. Hiemke, P.L. Lohmann, K. Grasmäder, Hans-Joachim Kuss, Matthias J. Müller, S. Härtter, E. Geiger, Miriam Fric, G. Laux
Publikováno v:
psychoneuro. 29:40-43
Therapeutisches Drug Monitoring (TDM) ist bei Verordnung eines Antidepressivums eine potenziell nützliche Therapieergänzung. Wenn TDM unter naturalistischen Bedingungen für trizyklische Antidepressiva eingesetzt wurde, waren die Blutspiegel depres
Autor:
Tdm Arbeitsgruppe der Agnp Federführend:M. L. Rao, Christoph Hiemke, P. Baumann, K. Grasmäder
Publikováno v:
Fortschritte der Neurologie · Psychiatrie. 69:580-582
Autor:
C Hiemke, André Tadić, Matthias J. Müller, K Grasmäder, M. L. Rao, G. Laux, E Ostad Haji, A. Dragicevic
Publikováno v:
Pharmacopsychiatry. 44
Autor:
M. L. Rao, G. Laux, K Grasmäder, A. Dragicevic, Joachim Röschke, Matthias J. Müller, Petra Louise Verwohlt, C Hiemke, Hans-Joachim Kuss, Klaus Mann
Publikováno v:
Pharmacopsychiatry. 40
Autor:
Petra Louise Verwohlt, O. von Widdern, W. Maier, A. Zobel, K Grasmäder, M. L. Rao, C Hiemke, Christine Frahnert, Kühn Ku, A. Dragicevic
Publikováno v:
Pharmacopsychiatry. 38(3)
Objective The aim of this study was to evaluate the benefit of mirtazapine plasma concentration monitoring in a typical clinical setting. Methods The relationship between mirtazapine plasma concentration, dose, response, and side effects was studied
Autor:
Joachim Röschke, B. Schanz, C Hiemke, A. Scherer, M. Fric, M. L. Rao, G. Laux, Sebastian Härtter, A. Dragicevic, J Sachse, E. Geiger, Matthias J. Müller, K Grasmäder, Hans-Joachim Kuss
Publikováno v:
Pharmacopsychiatry. 38
Autor:
Marie Luise Rao, Matthias J. Müller, K Grasmäder, N. Freymann, Astrid Zobel, A. Dragicevic, Wolfgang Maier, Petra Louise Verwohlt, Marcella Rietschel, Christoph Hiemke
Publikováno v:
European journal of clinical pharmacology. 60(5)
This evaluation focuses on polymorphisms of the cytochrome-P450 (CYP) isoenzymes 2C9, 2C19 and 2D6 and their association with plasma concentrations within a typical clinical setting. Side effects and treatment response were analysed in an exploratory
Autor:
M. L. Rao, A. Dragicevic, Matthias J. Müller, Hans-Joachim Kuss, E. Hermann, Harald Weigmann, Sebastian Härtter, W. Oehl, C Hiemke, M. Weber-Labonte, N. Rollmann, Gerd Laux, M. Fric, I. Gaertner, K Grasmäder
Publikováno v:
Pharmacopsychiatry. 36(3)
Therapeutic drug monitoring (TDM) of tricyclic antidepressants (TCA) is established in the treatment of depression to optimize outcome and safety. However, there are few reports on TDM under naturalistic clinical conditions. In the present study, we